ID: MRFR/LS/2428-CRR | April, 2017 | Region: Global | 82 pages | Cooked Research Reports
Market Synopsis of Global Biomarker Test Market:
Most healthcare professionals use diagnosis tests to clarify and support their clinical decision making. Progressively over recent years, the analytic procedure has turned out to be stronger by the need to preselect patients in light of medications and licenses. This move has come to through various factors, which incorporate propelling technology (empowering professionals to measure more particular markers of adequacy), an increased comprehension of the disease procedure, and a more prominent energy about the uniqueness of an individual's tumour at the molecular level. These components are reflected in the changing outline of clinical trials. But this move is driven by societal elements as well as, most noticeable among which is the need to limit targeted therapies to those patients destined to benefit. With the appearance of customized/precision prescription, the one-estimate fits-all approach is being consigned to history of life science..
The global market for Biomarker test is expected to reach USD 16,112.8 million by the end of the forecasted period 2016-2022 and is expected to grow at a CAGR of 14.5%.
Study Objectives Global Biomarker Test Market:
Global Biomarker Test Market, by Application, 2015 (%):
Key Players for Global Biomarker Test Market:
Some of the key players in this market are: F. Hoffmann-La Roche AG, Novartis AG, PFIZER INC., GlaxoSmithKline plc., GE Healthcare, Medtronics, Quest Diagnostics and others.
Global Biomarker test Market has been segmented on the basis of application which comprises of Cancer, Cardiovascular, Infectious Diseases, Central Nervous System. On the basis of end users which includes Pharma & Biotech Companies, Diagnostic tool companies, Healthcare IT/Big data companies, Clinical laboratories.
Regional Analysis of Global Biomarker Test Market:
The global market for Biomarker test is growing rapidly. The market for Biomarker test is growing with the CAGR of 14.5% during the forecast period from 2016-2022. North America accounts for largest market share in 2015 and is expected to reach USD 6,640.4 million by 2022.
Asia-Pacific region is the fastest growing market for Biomarker test, which is expected to grow at a CAGR of 15.2% during the forecast period from 2016 to 2022.
The report for Global Biomarker test Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions